Hospital
County of Los Angeles Auditor Controller
County of Los Angeles Auditor Controller was paid $1.73M by Medicaid between Jan 2018 and Sep 2024, across 80 billing codes. Its largest line is 0450, Emergency room services — 51% of everything it billed.
33Billing provider infoCOUNTY OF LOS ANGELES AUDITOR CONTROLLER
LOS ANGELES, CA 90033
LOS ANGELES, CA 90033
33aNPI1962568337assigned 12/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.73M
24GClaims88,039
24DCodes billed80
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#257 of 410
Median peer was paid$6.90M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,052 | $229K | |
| 2019 | 11,129 | $288K | |
| 2020 | 10,276 | $183K | |
| 2021 | 14,631 | $211K | |
| 2022 | 13,470 | $227K | |
| 2023 | 16,261 | $373K | |
| 2024incomplete | 9,220 | $215K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 51% | 13,506 | 12,484 | $875K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 16% | 4,740 | 4,302 | $280K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.9% | 1,261 | 1,207 | $85K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.8% | 3,975 | 3,570 | $83K |
| 74174 | 4.7% | 600 | 585 | $81K | |
| 99199 | Unlisted special service, procedure or report | 3.8% | 3,688 | 3,371 | $66K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 1,242 | 1,140 | $36K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 441 | 436 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 440 | 418 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,679 | 5,151 | $17K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,091 | 1,978 | $14K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 752 | 737 | $14K |
68 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,964 | $14K |
| 99283 | Emergency room visit (moderate) | <1% | 301 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 170 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,011 | $11K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,720 | $11K |
| 80076 | <1% | 3,733 | $9K | |
| 84484 | <1% | 1,817 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 929 | $6K |
| 83690 | <1% | 2,562 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 768 | $5K |
| 0250 | <1% | 7,664 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 590 | $4K |
| 83605 | <1% | 919 | $3K | |
| 85610 | <1% | 2,283 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 650 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 41 | $2K |
| 80047 | <1% | 402 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 123 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 124 | $2K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 449 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 327 | $2K |
| 83880 | <1% | 236 | $2K | |
| 86901 | <1% | 937 | $1K | |
| 86850 | <1% | 883 | $1K | |
| 86900 | <1% | 936 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 365 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 193 | $1K |
| 81000 | <1% | 860 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $1K |
| 0510 | <1% | 89 | $1K | |
| 81001 | <1% | 1,457 | $815.17 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,305 | $814.23 |
| 81015 | <1% | 423 | $727.47 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 12 | $645.00 |
| 84702 | <1% | 168 | $545.04 | |
| 87088 | <1% | 224 | $513.39 | |
| 81025 | <1% | 243 | $511.73 | |
| 80305 | <1% | 67 | $433.77 | |
| 82550 | <1% | 222 | $407.20 | |
| 85730 | <1% | 291 | $397.42 | |
| 86780 | <1% | 191 | $387.60 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 40 | $372.53 |
| 99284 | Emergency room visit (serious) | <1% | 13 | $341.75 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 232 | $335.81 |
| 0760 | <1% | 135 | $323.45 | |
| 86703 | <1% | 107 | $307.14 | |
| 86141 | <1% | 102 | $224.16 | |
| 90715 | <1% | 16 | $213.70 | |
| 81002 | <1% | 249 | $205.19 | |
| 73610 | <1% | 12 | $194.72 | |
| 73564 | <1% | 15 | $180.84 | |
| 0761 | <1% | 38 | $142.62 | |
| 73590 | <1% | 15 | $135.63 | |
| 87040 | <1% | 26 | $129.60 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 55 | $120.42 |
| 73130 | <1% | 15 | $113.55 | |
| 73090 | <1% | 14 | $95.70 | |
| 82962 | <1% | 61 | $83.21 | |
| 73110 | <1% | 12 | $77.47 | |
| G0378 | Hospital observation service, per hour | <1% | 42 | $76.06 |
| 81003 | <1% | 236 | $60.37 | |
| 85027 | <1% | 59 | $50.26 | |
| 86593 | <1% | 149 | $46.92 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13 | $42.97 |
| 86592 | <1% | 156 | $39.40 | |
| 87210 | <1% | 12 | $39.18 | |
| 80320 | <1% | 119 | $37.50 | |
| 0320 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCORBET, MARK (INTERIM CHIEF FINANCIAL OFFICER)
Parent organizationCOUNTY OF LOS ANGELES AUDITOR CONTROLLER
| Provider | Location | Paid |
|---|---|---|
| County of Los Angeles Auditor Controller | Los Angeles, CA | $329K |
| County of Los Angeles Auditor Controller | Los Angeles, CA | $322K |
| County of Los Angeles Auditor Controller | Downey, CA | $173K |
| County of Los Angeles Auditor Controller | Los Angeles, CA | $100K |
| County of Los Angeles Auditor Controller | Los Angeles, CA | $100K |
| County of Los Angeles Auditor Controller | Sylmar, CA | $89K |
| County of Los Angeles Auditor Controller | El Monte, CA | $49K |
| County of Los Angeles | Los Angeles, CA | $18K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.